Email Updates

You are here

AVAC Comments to FDA in Support of PrEP Approval

top

AVAC
May 2012

Comments delivered to the FDA’s Antiviral Drugs Advisory Committee (AVDAC) Meeting by Mitchell Warren, Executive Director, AVAC.